tiprankstipranks
Quince Therapeutics presents safety data from ATTeST trial at CNS meeting
PremiumThe FlyQuince Therapeutics presents safety data from ATTeST trial at CNS meeting
3M ago
Quince Therapeutics initiated with a Buy at Maxim
Premium
The Fly
Quince Therapeutics initiated with a Buy at Maxim
4M ago
Quince Therapeutics initiated with a Buy at Rodman & Renshaw
Premium
The Fly
Quince Therapeutics initiated with a Buy at Rodman & Renshaw
4M ago
Quince Therapeutics Appoints Rajiv Patni to Board of Directors
PremiumCompany AnnouncementsQuince Therapeutics Appoints Rajiv Patni to Board of Directors
1y ago
Quince Therapeutics Executive Compensation and Stock Option Update
Premium
Company Announcements
Quince Therapeutics Executive Compensation and Stock Option Update
1y ago
Quince Therapeutics says FDA lifts partical clinical hold on EryDel’s EryDex IND
Premium
The Fly
Quince Therapeutics says FDA lifts partical clinical hold on EryDel’s EryDex IND
1y ago
Quince Therapeutics engages MTS Heath Partners to review strategic alternatives
PremiumThe FlyQuince Therapeutics engages MTS Heath Partners to review strategic alternatives
2y ago
Quince Therapeutics confirms unsolicited acquisition offer from Echo Lake
Premium
The Fly
Quince Therapeutics confirms unsolicited acquisition offer from Echo Lake
2y ago
QNCX Soars on $1.60 Per Share Bid from Echo Lake
Premium
Market News
QNCX Soars on $1.60 Per Share Bid from Echo Lake
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100